[PDF] Top 20 Risk-Based Simulation Optimization of PSA-Based Prostate Cancer Screening
Has 10000 "Risk-Based Simulation Optimization of PSA-Based Prostate Cancer Screening" found on our website. Below are the top 20 most common "Risk-Based Simulation Optimization of PSA-Based Prostate Cancer Screening".
Risk-Based Simulation Optimization of PSA-Based Prostate Cancer Screening
... patient’s PSA value increases by a percentage (plus a small random error) that depends on the patient’s cancer stage and stage ...different screening strategies on the basis of benefits harms, ... See full document
250
Simulation Optimization of Prostate Cancer Screening Using a Parallel Genetic Algorithm.
... of prostate cancer treatment, a summary of which we introduce ...the prostate gland is ...the prostate gland, and bracytherapy requires a radioactive substance to be implanted into and beside ... See full document
68
A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy.
... The risk of having a biopsy-detectable csPCa is based on 3616 men who received transrectal ultrasound-guided sextant biopsies in the first screening round of the Dutch arm of the ERSPC ...biopsy, ... See full document
10
Effect of church based intervention to promote informed decision making for prostate cancer screening among adult men attending saint Mary’s catholic church, Enugu, Nigeria
... about screening practices for prostate cancer while 41(82%) affirmed that screening can reduce a man’s risk of dying of prostate cancer and that men could live longer if ... See full document
8
A case-cohort study of human herpesvirus 8 seropositivity and incident prostate cancer in Tobago
... Tobago Prostate Survey is an ongoing population- based longitudinal study of prostate cancer screening, as well as risk, in ≥ 40 year-old men living in Tobago ...[24]. ... See full document
9
Correlation of PSA Density to Prostate Cancer Based on Prostate Volume by 3 0 T MRI
... in screening patients for prostate cancer risk ...increase PSA [1]. Cur- rent PSA recommendations lead to significant over- treatment and associated morbidity from unnecessary ... See full document
9
The role of modelling in the policy decision making process for cancer screening: example of prostate specific antigen screening
... on cancer screening, it remains difficult to assess all downstream effects of screening, particularly when screening options other than those in the specific trial design are being ... See full document
5
Men with a susceptibility to prostate cancer and the role of genetic based screening.
... of prostate cancer have a significantly higher lifetime risk of developing the disease, with a 2- to 8-fold increase reported (7) and worsening risk with the number of first degree relatives ... See full document
9
PSA testing for men at average risk of prostate cancer
... national PSA testing program akin to the national breast cancer screening program (for example) would not be recommended, and that the reported results of the European Randomized Study of ... See full document
6
Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.
... relative risk of PC among cases relative to controls for each SNP ...relative risk of more aggressive and less aggressive PC relative to controls for each SNP ...diagnostic PSA value >20 ...PC ... See full document
17
Study of Correlation between Prostate Specific Antigen and Matrix Metalloproteinase-2 Activity in Benign and Malignant Prostate Hyperplasia
... degradation during tumor invasion and metastasis, in particular, to be specifically associated with PC metastasis [8-13]. Since molecules released as the results of tissue alterations are often found in body fluids, the ... See full document
6
The relationship between Agent Orange and prostate specific antigen: a comparison of a hotspot and a non-sprayed area in Vietnam
... abnormal PSA levels (PSA [ 4 ng/mL) in the cohort exposed to Agent Orange than in the unex- posed cohort ...that PSA levels increased in all cases except ...detected prostate gland ... See full document
5
Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents
... Where categorization is based on quantiles, it becomes difficult to compare results across different studies. For example, two recent papers described the effect of hos- pital volume on mortality rates after a ... See full document
5
Role of 5 alpha-reductase inhibitors in the management of prostate cancer
... Identification of individuals with congenital deficiency of 5AR has served as a naturally occurring model ultimately leading to the development of a pharmacologic inhibitor of 5AR. Finasteride is an orally active, ... See full document
8
<p>Short-term benefit of neoadjuvant hormone therapy in patients with localized high-risk or limited progressive prostate cancer</p>
... NHT for patients is still not recommended in various guide- lines because it does not signi fi cantly improve the patients ’ prognosis. 2-4 However, regardless of its effects on prog- nosis, we should pay attention to the ... See full document
9
Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
... Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Philadelphia (PA): Lippin[r] ... See full document
20
Psychosocial factors that influence men's help seeking for cancer symptoms: a systematic synthesis of mixed methods research
... that cancer prevention initiatives to improve men’s help-seeking behaviour should aim to increase cancer knowledge, reduce embarrassment and fear, address social norms deterring timely help- seeking, and ... See full document
43
Exponential Rise in Prostate Specific Antigen (PSA) during Anti Androgen Withdrawal Predicts PSA Flare after Docetaxel Chemotherapy in Patients with Castration Resistant Prostate Cancer
... Patient characteristics of the study sample are summarized in Table 1. The median age was 69 years old (range, 54 to 84), and the median follow-up period from the start of chemo- therapy was 13.5 months (range, 3.0 to ... See full document
7
Practice Patterns of Korean Urologists for Screening and Managing Prostate Cancer according to PSA Level
... of prostate biopsy by dividing only PSA level and digital rectal examination finding was not ...the PSA value might have occurred: despite the narrowing in differences among PSA assays since ... See full document
6
PSA Screening for Prostate Cancer in Men under the Age of 65: A Review of Current Practice
... of Prostate Specific Antigen (PSA) testing and assess the overall risks and benefits of PSA testing for Ade- nocarcinoma of the Prostate, specifically in men under age 65, and those liv- ing ... See full document
26
Related subjects